Regular aspirin use and lung cancer risk (Q24803838)

6 July 2017

title

Regular aspirin use and lung cancer risk (English)

1 reference

6 July 2017

0 references

1 reference

1

Kirsten B Moysich

1 reference

6 July 2017

Ravi J Menezes

2

1 reference

6 July 2017

Adrienne Ronsani

3

1 reference

6 July 2017

Helen Swede

4

1 reference

6 July 2017

Mary E Reid

5

1 reference

6 July 2017

K Michael Cummings

6

1 reference

6 July 2017

Karen L Falkner

7

1 reference

6 July 2017

Gregory M Loewen

8

1 reference

6 July 2017

Gerold Bepler

9

1 reference

6 July 2017

language of work or name

English

0 references

publication date

26 November 2002

1 reference

6 July 2017

1 reference

6 July 2017

volume

2

1 reference

6 July 2017

issue

1

0 references

page(s)

31

1 reference

Aspirin and lung cancer in women

6 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=138809

Chemoprevention of lung cancer by non-steroidal anti-inflammatory drugs among cigarette smokers

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=138809

Aspirin and epithelial ovarian cancer

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=138809

Regular use of analgesic drugs and ovarian cancer risk

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=138809

Aspirin use and chronic diseases: a cohort study of the elderly

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=138809

7 April 2017

Cyclooxygenases 1 and 2

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=138809

Effect of anti-inflammatory drugs on overall risk of common cancer: case-control study in general practice research database

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=138809

Colorectal cancer prevention by non-steroidal anti-inflammatory drugs: effects of dosage and timing

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=138809

The role of cyclooxygenase inhibition in the antineoplastic effects of nonsteroidal antiinflammatory drugs (NSAIDs)

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=138809

Colon cancer prevention by NSAIDs: what is the mechanism of action?

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=138809

Expression of cyclooxygenase-2 in human lung carcinoma

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=138809

Induction of apoptosis in colon cancer cells by nonsteroidal anti-inflammatory drugs

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=138809

Aspirin use and risk of fatal cancer

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=138809

Nonsteroidal Anti-inflammatory Drugs and Cancer

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=138809

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=138809

Randomised trial of prophylactic daily aspirin in British male doctors

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=138809

Vasectomy and prostate cancer risk

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=138809

Aspirin and gastrointestinal cancer

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=138809

Nonsteroidal antiinflammatory drug use and reduced risk of large bowel carcinoma

30 May 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-2-31

Aspirin, NSAIDS, and colon cancer prevention: mechanisms?

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-2-31

Aspirin protects against gastric cancer: results of a case-control study from Moscow, Russia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-2-31

Nonsteroidal antiinflammatory drugs and breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-2-31

Cyclooxygenase-2 (COX-2) mRNA expression levels in normal lung tissues and non-small cell lung cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-2-31

Increased cyclooxygenase 2 (COX-2) expression occurs frequently in precursor lesions of human adenocarcinoma of the lung.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-2-31

Use of aspirin and other nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=138809

Aspirin and reduced risk of esophageal carcinoma

28 November 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-2-31

Aspirin use and lung, colon, and breast cancer incidence in a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-2-31

The Relationship of Nonsteroidal Anti-inflammatory Drug Use to the Risk of Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-2-31

Cyclooxygenase-2 inhibitors in tumorigenesis (part I)

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-2-31

High cyclooxygenase 1 (COX-1) and cyclooxygenase 2 (COX-2) contents in mouse lung tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-2-31

Chemopreventive efficacies of aspirin and sulindac against lung tumorigenesis in A/J mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-2-31

Aspirin use, cancer, and polyps of the large bowel

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-2-31

The association of age and familial risk in a case-control study of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-2-31

Milk drinking, other beverage habits, and lung cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-2-31

A case-control study of analgesic use and ovarian cancer

21 January 2018

1 reference

12 December 2020

Non-small cell lung cancer cycloxygenase activity and proliferation are inhibited by non-steroidal antiinflammatory drugs

1 reference

12 December 2020

Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas

1 reference

12 December 2020

Increased expression of COX-2 in the development of human lung cancers

1 reference

12 December 2020

Tubal ligation and the risk of ovarian carcinoma

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-2407-2-31

1 reference

Dimensions Publication ID

6 July 2017

0 references

1 reference

6 July 2017

1 reference